| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |